Ricardo Amorim

Has grant

Junior Researcher

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto
Country flagPortugal

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Adipocyte Browning: the missing link for peritoneal metastasis in diffuse gastric cancer

Open Date: 2025-02-03

Close Date: 2026-08-02

Grant: Close

CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

Open Date: 2023-07-01

Close Date:

Grant: Close

Remodelação metabólica e mitocondrial induzida pela atividade física em fibroblastos de pacientes com a Doença de Parkinson

Open Date: 2023-01-01

Close Date:

Grant: Close

Human Neuronal Cells Differentiated from Urine-derived Stem Cells as a Platform for Personalized Medicine in Amyotrophic Lateral Sclerosis

Open Date: 2021-01-01

Close Date:

Grant: Close

CôaMedPlants: Preservation of natural and cultural heritage and scientific validation of practices with medicinal plants from Côa Valley

Open Date: 2019-06-01

Close Date: 2023-01-01

Articles (3)

Year:

2024

Year:

2024

Non-alcoholic fatty liver disease (NAFLD) is a global pandemic affecting 25% of the world’s population and is a serious health and economic concern worldwide. NAFLD is mainly the result of unhealthy dietary habits combined with sedentary lifestyle, although some genetic contributions to NAFLD have been documented. NAFLD is characterized by the excessive accumulation of triglycerides (TGs) in hepatocytes and encompasses a spectrum of chronic liver abnormalities, ranging from simple steatosis (NAFL) to steatohepatitis (NASH), significant liver fibrosis, cirrhosis, and hepatocellular carcinoma. Although the molecular mechanisms that cause the progression of steatosis to severe liver damage are not fully understood, metabolic-dysfunction-associated fatty liver disease is strong evidence that mitochondrial dysfunction plays a significant role in the development and progression of NAFLD. Mitochondria are highly dynamic organelles that undergo functional and structural adaptations to meet the metabolic requirements of the cell. Alterations in nutrient availability or cellular energy needs can modify mitochondria formation through biogenesis or the opposite processes of fission and fusion and fragmentation. In NAFL, simple steatosis can be seen as an adaptive response to storing lipotoxic free fatty acids (FFAs) as inert TGs due to chronic perturbation in lipid metabolism and lipotoxic insults. However, when liver hepatocytes’ adaptive mechanisms are overburdened, lipotoxicity occurs, contributing to reactive oxygen species (ROS) formation, mitochondrial dysfunction, and endoplasmic reticulum (ER) stress. Impaired mitochondrial fatty acid oxidation, reduction in mitochondrial quality, and disrupted mitochondrial function are associated with a decrease in the energy levels and impaired redox balance and negatively affect mitochondria hepatocyte tolerance towards damaging hits. However, the sequence of events underlying mitochondrial failure from steatosis to hepatocarcinoma is still yet to be fully clarified. This review provides an overview of our understanding of mitochondrial adaptation in initial NAFLD stages and highlights how hepatic mitochondrial dysfunction and heterogeneity contribute to disease pathophysiology progression, from steatosis to hepatocellular carcinoma. Improving our understanding of different aspects of hepatocytes’ mitochondrial physiology in the context of disease development and progression is crucial to improving diagnosis, management, and therapy of NAFLD/NASH.

Year:

2023

Collaborators (3)

Ludgero Tavares

Assistant Professor

Escola Universitária Vasco da Gama

PORTUGAL
View details

José Teixeira

Professor Auxiliar

University of Coimbra

PORTUGAL
View details

Paulo Oliveira

Invited Assistant Professor

University of Coimbra

PORTUGAL
View details